Specificity studies on Kallikrein-related peptidase 7 (KLK7) and effects of osmolytes and glycosaminoglycans on its peptidase activity

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1854, Issue 1, 2015, Pages 73-83

  Oliveira, Juliana R ^a   Bertolin, Thiago C ^a   Andrade, Douglas ^a   Oliveira, Lilian C G ^a   Kondo, Marcia Y ^a   Santos, Jorge A N ^a,d   Blaber, Michael ^b   Juliano, Luiz ^a   Severino, Beatrice ^c   Caliendo, Giuseppe ^c   Santagada, Vincenzo ^c   Juliano, Maria A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d INSTITUTO FEDERAL DE EDUCAÇÃO   (Brazil)

Author keywords

Kallistatin; Kosmotropic salts; Proteolytic enzymes; Semaphorin; Skin

Indexed keywords

AMINO ACID; ANTHRANILIC ACID; GLUTAMIC ACID DERIVATIVE; GLUTAMINYL N [2,4 DINITROPHENYL] ETHYLENEDIAMINE; GLYCOSAMINOGLYCAN; INORGANIC SALT; KALLIKREIN; KININOGEN; PEPTIDASE; PYROGLUTAMIC ACID; RESIN; SEMAPHORIN; SEMAPHORIN 6B; SODIUM CHLORIDE; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; SUBSTANCE P; UNCLASSIFIED DRUG; KALLISTATIN; KLK7 PROTEIN, HUMAN; PEPTIDE; PEPTIDE HYDROLASE; SERINE PROTEINASE INHIBITOR; SOMATOSTATIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; ENZYME SPECIFICITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GASTROINTESTINAL TRACT; HYDROLYSIS; NONHUMAN; PATHOPHYSIOLOGY; PEPTIDE LIBRARY; PEPTIDE SYNTHESIS; BINDING SITE; BIOCATALYSIS; DRUG EFFECTS; HUMAN; KINETICS; METABOLISM; MOLECULAR GENETICS; OSMOLARITY; TIME;

AMINO ACID SEQUENCE; BINDING SITES; BIOCATALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GLYCOSAMINOGLYCANS; HUMANS; HYDROLYSIS; KALLIKREINS; KINETICS; KININOGENS; MOLECULAR SEQUENCE DATA; OSMOLAR CONCENTRATION; PEPTIDE HYDROLASES; PEPTIDES; PYRROLIDONECARBOXYLIC ACID; SEMAPHORINS; SERPINS; SOMATOSTATIN; SUBSTANCE P; SUBSTRATE SPECIFICITY; TIME FACTORS;

EID: 84912118536     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2014.10.018     Document Type: Article

References (75)

1. A. Lundwall, V. Band, M. Blaber, J.A. Clements, Y. Courty, E.P. Diamandis, H. Fritz, H. Lilja, J. Malm, L.J. Maltais, A. Yvonne Olsson, C. Petraki, A. Scorilas, G. Sotiropoulou, U.H. Stenman, C. Stephan, M. Talieri, and G.M. Yousef A comprehensive nomenclature for serine proteases with homology to tissue kallikreins Biol. Chem. 387 2006 637 641
2. D. Cretu, G.M. Yousef, A. Scorilas, and E.P. Diamandis Genomic structure of the KLK locus V. Magdolen, C.P. Sommerhoff, H. Fritz, M. Schmitt, Kallikrein - Related Peptidases vol. 1 2012 De Gruyter Berlin, Germany 5 29
3. L. Gan, I. Lee, R. Smith, R. Argonza-Barrett, H. Lei, J. McCuaig, P. Moss, B. Paeper, and K. Wang Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region Gene 257 2000 119 130
4. T.J. Harvey, J.D. Hooper, S.A. Myers, S.A. Stephenson, L.K. Ashworth, and J.A. Clements Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4 J. Biol. Chem. 275 2000 35397 35406
5. G.M. Yousef, A. Chang, A. Scorilas, and E.P. Diamandis Genomic organization of the human kallikrein gene family on chromosome 19q13.3 - q13.4 Biochem. Biophys. Res. Commun. 276 2000 125 133
6. A. Lundwall, and M. Brattsand Kallikrein-related peptidases Cell. Mol. Life Sci. 65 2008 2019 2038
7. T. Egelrud, and A. Lundstrom A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum Arch. Dermatol. Res. 283 1991 108 112
8. L. Hansson, M. Stromqvist, A. Backman, P. Wallbrandt, A. Carlstein, and T. Egelrud Cloning, expression and characterization of stratum corneum chymotryptic enzyme. A skin - specific human serine proteinase J. Biol. Chem. 269 1994 19420 19426
9. M. Brattsand Kallikrein-related peptidases and inhibitors of the skin V. Magdolen, C.P. Sommerhoff, H. Fritz, M. Schmitt, Kallikrein - Related Peptidases vol. 1 2012 De Gruyter Berlin, Germany 329 347
10. K. Yamasaki, J. Schauber, A. Coda, H. Lin, R.A. Dorschner, N.M. Schechter, C. Bonnart, P. Descargues, A. Hovnanian, and R.L. Gallo Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin FASEB J. 20 2006 2068 2080
11. C.A. Borgoño, I.P. Michael, N. Komatsu, A. Jayakumar, R. Kapadia, G.L. Clayman, G. Sotiropoulou, and E.P. Diamandis A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation J. Biol. Chem. 282 2007 3640 3652
12. C. Caubet, N. Jonca, M. Brattsand, M. Guerrin, D. Bernard, R. Schmidt, T. Egelrud, M. Simon, and G. Serre Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7 J. Invest. Dermatol. 122 2004 1235 1244
13. J. Fischer, and U. Meyer-Hoffert Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options Thromb. Haemost. 110 2013 442 449
14. J.L.V. Shaw, and E.P. Diamandis Distribution of 15 human kallikreins in tissues and biological fluids Clin. Chem. 53 2007 1423 1432
15. T. Kishi, A. Soosaipillai, L. Grass, S.P. Little, E.M. Johnstone, and E.P. Diamandis Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids Clin. Chem. 50 2004 709 716
16. I. Schechter, and A. Berger On the size of the active site in proteases. I. Papain Biochem. Biophys. Res. Commun. 27 1967 157 162
17. P.F. Ângelo, A.R. Lima, F.M. Alves, S.I. Blaber, I.A. Scarisbrick, M. Blaber, L. Juliano, and M.A. Juliano Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects J. Biol. Chem. 281 2006 3116 3126
18. M. Debela, P. Hess, V. Magdolen, N.M. Schechter, T. Steiner, R. Huber, W. Bode, and P. Goettig Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein Proc. Natl. Acad. Sci. U. S. A. 104 2007 16086 16091
19. I.S. Fernández, L. Ständker, H.-J. Mägert, W.-G. Forssmann, G.G. Gallego, and A. Romero Crystal structure of human epidermal kallikrein 7 synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 J. Mol. Biol. 377 2008 1488 1497
20. M. Debela, V. Magdolen, N. Schechter, M. Valachova, F. Lottspeich, C.S. Craik, Y. Choe, W. Bode, and P. Goettig Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences J. Biol. Chem. 281 2006 25678 25688
21. M. Meldal, I. Svendsen, K. Breddam, and F.I. Auzanneau Portion-mixing peptide libraries of quenched fluorogenic substrates for complete subsite mapping of endoprotease specificity Proc. Natl. Acad. Sci. U. S. A. 91 1994 3314 3318
22. F.M. Alves, I.Y. Hirata, I.E. Gouvea, M.F. Alves, M. Meldal, D. Brömme, L. Juliano, and M.A. Juliano Controlled peptide solvation in portion-mixing libraries of FRET peptides: improved specificity determination for Dengue 2 virus NS2B-NS3 protease and human cathepsin S J. Comb. Chem. 9 2007 627 634
23. L.C. Oliveira, V.O. Silva, D.N. Okamoto, M.Y. Kondo, S.M. Santos, I.Y. Hirata, M.A. Vallim, R.C. Pascon, I.E. Gouvea, M.A. Juliano, and L. Juliano Internally quenched fluorescent peptide libraries with randomized sequences designed to detect endopeptidases Anal. Biochem. 421 2012 299 307
24. B.U. Wintroub, N.B. Schechter, G.S. Lazarus, C.E. Kaempfer, and L.B. Schwartz Angiotensin I conversion by human and rat chymotryptic proteinases J. Invest. Dermatol. 83 1984 336 339
25. A. Skytt, M. Stromqvis, and T. Egelrud Primary substrate specificity of recombinant human stratum corneum chymotryptic enzyme Biochem. Biophys. Res. Commun. 211 1995 586 589
26. C. Scarpignato, and I. Pelosini Somatostatin for upper gastrointestinal hemorrhage and pancreatic surgery. A review of its pharmacology and safety Digestion 60 Suppl. 3 1999 1 16
27. E. Hagforsen, G. Michaëlsson, and M. Stridsberg Somatostatin receptors are strongly expressed in palmoplantar sweat glands and ducts: studies of normal and palmoplantar pustulosis skin Clin. Exp. Dermatol. 36 2011 521 527
28. A. Gaudillère, L. Misery, C. Bernard, C. Souchier, A. Claudy, and D. Schmitt Presence of somatostatin in normal human epidermis Br. J. Dermatol. 137 1997 376 380
29. M. Vockel, U. Breitenbach, H.J. Kreienkamp, and J.M. Brandner Somatostatin regulates tight junction function and composition in human keratinocytes Exp. Dermatol. 19 2010 888 894
30. E.M. Peters, M.E. Ericson, J. Hosoi, K. Seiffert, M.K. Hordinsky, J.C. Ansel, R. Paus, and T.E. Scholzen Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance J. Invest. Dermatol. 126 2006 1937 1947
31. G.J. Burbach, K.H. Kim, A.S. Zivony, A. Kim, J. Aranda, S. Wright, S.M. Naik, S.W. Caughman, J.C. Ansel, and C.A. Armstrong The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor J. Invest. Dermatol. 117 2001 1075 1082
32. A.J. Mitchell, A.M. Lone, A.D. Tinoco, and A. Saghatelian Proteolysis controls endogenous substance P levels PLoS One 8 2013 e68638
33. D.C. Pimenta, J. Chao, L. Chao, M.A. Juliano, and L. Juliano Specificity of human tissue kallikrein towards substrates containing Phe - Phe pair of amino acids Biochem. J. 339 1999 473 479
34. D. Andrade, D.M. Assis, A.R. Lima, J.R. Oliveira, M.S. Araujo, S.I. Blaber, M. Blaber, M.A. Juliano, and L. Juliano Substrate specificity and inhibition of human kallikrein-related peptidase 3 (KLK3 or PSA) activated with sodium citrate and glycosaminoglycans Arch. Biochem. Biophys. 498 2010 74 82
35. D. Andrade, D.M. Assis, J.A. Santos, F.M. Alves, I.Y. Hirata, M.S. Araujo, S.I. Blaber, M. Blaber, M.A. Juliano, and L. Juliano Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates Biochimie 93 2011 1701 1709
36. M. Schindewolf, E. Lindhoff -Last, R.J. Ludwig, and W.H. Boehncke Heparin-induced skin lesions Lancet 380 2012 1867 1879
37. J. Fisher, and U.F. Hoffert Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options Thromb. Haemost. 110 2013 442 449
38. G. Pampalakis, and G. Sotiropoulou Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer Biochim. Biophys. Acta 1776 2007 22 31
39. K. Levi, J. Baxter, H. Meldrum, M. Misra, E. Pashkovski, and R.H. Dauskardt Effect of corneodesmosome degradation on the intercellular delamination of human stratum corneum J. Invest. Dermatol. 128 2008 2345 2347
40. E. Ekholm, and T. Egelrud Stratum corneum chymotryptic enzyme in psoriasis Arch. Dermatol. Res. 291 1999 195 200
41. N. Komatsu, K. Saijoh, M. Sidiropoulos, B. Tsai, M.A. Levesque, M.B. Elliott, K. Takehara, and E.F. Diamandis Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender J. Invest. Dermatol. 125 2005 1182 1189
42. C.R. Harding, A. Watkinson, and A.V. Rawlings Dry skin, moisturization and corneodesmolysis Int. J. Cosmet. Sci. 22 2000 21 52
43. S.V. Sévrain, and F. Bonté Skin hydration: a review on its molecular mechanisms J. Cosmet. Dermatol. 6 2007 75 82
44. S. Kezic, A. Kammeyer, F. Calkoen, J.W. Fluhr, and J.D. Bos Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods Br. J. Dermatol. 161 2009 1098 1104
45. X. Huang, C.T. Knoell, G. Frey, M. Hazegh-Azam, A.H. Tashjian, L. Hedstrom, R.H. Abeles, and S.N. Timasheff Modulation of recombinant human prostate specific antigen: activation by Hofmeister salts and inhibition by azapeptides. Appendix: thermodynamic interpretation of the activation by concentrated salts Biochemistry 40 2001 11734 11741
46. W. Lieberthal, N.B. Oza, D.B. Bernard, and N.G. Levinsky The effect of cations on the activity of human urinary kallikrein J. Biol. Chem. 257 1982 10827 10830
47. E. Del Nery, J.R. Chagas, M.A. Juliano, E.S. Prado, and L. Juliano Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments Biochem. J. 312 1995 233 238
48. M.O. Sousa, M.M. Santoro, and A.F. Figueiredo The effect of cations on the amidase activity of human tissue kallikrein: linear competitive inhibition by sodium, potassium, calcium and magnesium. Linear mixed inhibition by aluminium J. Enzyme Inhib. Med. Chem. 19 2004 317 325
49. G. Laxmikanthan, S.I. Blaber, M.J. Bernett, I.A. Scarisbrick, M.A. Juliano, and M. Blaber 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding Proteins 58 2005 802 814
50. G.W. Jameson, D.V. Roberts, R.W. Adams, W.S.A. Kyle, and D.T. Elmore Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration Biochem. J. 131 1973 107 117
51. I. Hirata, M.H.C. Cezari, C.R. Nakaie, P. Boshcov, A.S. Ito, M.A. Juliano, and L. Juliano Internally quenched fluorogenic protease substrates: solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzoyl/dinitrophenyl groups as donor-acceptor pairs Lett. Pept. Sci. 1 1994 299 308
52. B. Korkmaz, S. Attucci, M.A. Juliano, T. Kalupov, M.L. Jourdan, L. Juliano, and F. Gauthier Measuring elastase, proteinase 3, and cathepsin G activities at the surface of human neutrophils with fluorescence energy transfer substrates Nat. Protoc. 3 2008 991 1000
53. M. Roice, I. Johannsen, and M. Meldal High capacity poly (ethylene glycol) based amino polymers for peptide and organic synthesis QSAR Comb. Chem. 23 2004 662 673
54. C.P. Dietrich, I.L. Tersariol, L. Toma, C.T. Moraes, M.A. Porcionatto, F.W. Oliveira, and H.B. Nader Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins Cell. Mol. Biol. 44 1998 417 429
55. R.G. Correa, R.M. Sasahara, M.H. Bengtson, M.L.H. Katayama, A.C.M. Salim, M.M. Brentani, M.C. Sogayar, S.J. Souza, and A.J.G. Simpson Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent down regulation in glioblastoma cell lines Genomics 73 2001 343 348
56. B.E. Turk, L.L. Huang, E.T. Piro, and L.C. Cantley Determination of protease cleavage site motifs using mixture-based oriented peptide libraries Nat. Biotechnol. 19 2001 661 667
57. M. Tominaga, and K. Takamori Itch and nerve fibers with special reference to atopic dermatitis: therapeutic implications J. Dermatol. 41 2014 205 212
58. K. Kou, F. Nakamura, M. Aihara, H. Chen, K. Seto, J. Komori-Yamaguchi, T. Kambara, Y. Nagashima, Y. Goshima, and Z. Ikezawa Decreased expression of semaphorin-3A, a neurite-collapsing factor, is associated with itch in psoriatic skin Acta Derm. Venereol. 92 2012 521 528
59. S. Takada, K. Kou, Y. Nagashima, Z. Ikezawa, and M. Aihara Aberrant epidermal expression of semaphorin 3A and nerve growth factor in prurigo nodularis J. Dermatol. 40 2013 404 406
60. P. Prezas, A. Scorilas, C. Yfanti, P. Viktorov, N. Agnanti, E.P. Diamandis, and M. Talieri The role of human tissue kallikreins 7 and 8 in intracranial malignancies Biol. Chem. 387 2006 1607 1612
61. N.M. Ng, R.N. Pike, and S.E. Boyd Subsite cooperativity in protease specificity Biol. Chem. 390 2009 401 407
62. D.C. Pimenta, M.A. Juliano, and L. Juliano Hydrolysis of somatostatin by human tissue kallikrein after the amino acid pair Phe - Phe Biochem. J. 327 1997 27 30
63. M.M. Chan, M.M. Chan, J.A. Mengshol, N. Fish, and E.D. Chan Octreotide: a drug often used in the critical care setting but not well understood Chest 144 2013 1937 1945
64. 2 ′ positions in design of inhibitors Biochem. J. 371 2003 1021 1025
65. A. Hovnanian Netherton syndrome: skin inflammation and allergy by loss of protease inhibition Cell Tissue Res. 351 2013 289 300
66. S.J. de Veer, L. Furio, J.M. Harris, and A. Hovnanian Proteases: common culprits in human skin disorders Trends Mol. Med. 20 2014 166 178
67. J.R. Chagas, F.C. Portaro, I.Y. Hirata, P.C. Almeida, M.A. Juliano, L. Juliano, and E.S. Prado Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins Biochem. J. 306 1995 63 69
68. V. Iacobazzi, and V. Infantino Citrate - new functions for an old metabolite Biol. Chem. 395 2014 387 399
69. S.B. Zimmerman, and A.P. Minton Macromolecular crowding: biochemical, biophysical, and physiological consequences Annu. Rev. Biophys. Biomol. Struct. 22 1993 27 65
70. R.J. Ellis Macromolecular crowding: obvious but underappreciated Trends Biochem. Sci. 26 2001 597 604
71. S. Mukherjee, M.M. Waegele, P. Chowdhury, L. Guo, and F. Gai Effect of macromolecular crowding on protein folding dynamics at the secondary structure level J. Mol. Biol. 393 2009 227 236
72. D.D.L. Minh, C. Chang, J. Trylska, V. Tozzini, and J.A. McCammon The influence of macromolecular crowding on HIV-1 protease internal dynamics J. Am. Chem. Soc. 128 2006 6006 6007
73. A.K. Shaw, and S.K. Pal Activity of subtilisin Carlsberg in macromolecular crowding J. Photochem. Photobiol. B 86 2007 199 206
74. S. Marstein, E. Jellum, and L. Eldjarn The concentration of pyroglutamic acid (2-pyrrolidone-5-carboxylic acid) in normal and psoriatic epidermis, determined on a microgram scale by gas chromatography Clin. Chim. Acta 49 1973 389 395
75. A. Kumar, and A.K. Bachhawat Pyroglutamic acid: throwing light on a lightly studied metabolite Curr. Sci. 102 2012 288 297